BACKGROUND Children with sickle cell disease (SCD) are at increased risk for bloodstream
infections (BSIs), mainly because of functional asplenia. Immunizations and antibiotic …

Background There have been significant changes in clinical guidelines for sickle cell
disease (SCD) over the past two decades, including updated indications for hydroxyurea, …

Allogeneic hematopoietic cell therapy (HCT) is an established cure for sickle cell disease (SCD);
however, HCT conditioning regimens are known to be gonadotoxic. Anti-mullerian …

Background Understanding the distribution of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) antibodies from vaccination and/or prior infection is critical to the public …

Children with sickle cell disease (SCD) are at increased risk of invasive pneumococcal
disease (IPD). Over 25 years, the Georgia Emerging Infections Program/Centers for Disease …

Methods: Retrospective review of electronic health records from a large, multicampus, pediatric
SCD program. Results: Of the 113 adolescents included, the mean age was 16.6 (SD 0.9)…

Importance Understanding how SARS-CoV-2 seroprevalence varies regionally across
California is critical to the public health response to the pandemic. Objective To estimate how …

Objectives Recent studies have evaluated COVID‐19 outbreaks and excess mortality by
occupation sectors. Studies on SARS‐CoV‐2 infection across occupation and occupation‐…

Background: Influenza causes greater morbidity in children with cancer or sickle cell disease
(SCD). Literature on influenza vaccination receipt for these populations is limited in low-…

Activation of macrophages via toll‐like receptors (TLRs) is important for inflammation and
host defense against pathogens. Recent data suggest that non‐pathogenic molecules …